OHR Pharmaceutical Company

OHR Pharmaceutical develops products for the treatment of cancer cachexia and wet age-related macular degeneration.

Founded Date: 2009
Last Funding Type: Venture - Series Unknown
Headquarters: New York, New York, United States
Investors Number: 1
Technology: Small Molecules
Employee Number: 1-10
Industry: PharmTech
Estimated Revenue: Less than $1M
Funding Status: IPO
Total Funding: $3M